1264.3.01040 Boehringer Ingelheim Investigational Site

Killeen, Texas

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks — Completed